Suzhou ASTRABIO Co., Ltd.

Association of mitochondrial genome variants with Alzheimer's disease in a Chinese population 【Abstract】 【Background】 Research on the mitochondrial genome var...

 Engineered Alzheimer Organoids Validate the Link Between Intracellular and Soluble p‑Tau Biomarkers and Highlight the Contribution of Astrocytic Tau 【Abstract】 Sol...

Multidimensional modeling of biological aging: integrating gait, eye movement, rest-state functional connectivity, and plasma biomarkers in non-dementia older adults 【Abstra...

A prospective real-world study of the efficacy and safety of aducanumab in China: Focus on early-onset and autosomal dominant Alzheimer's disease 【Highlights】 1、...

Plasma biomarker changes following deep cervical lymphatic venous anastomosis An exploratory study in Alzheimer's disease using single-molecule array technology 【Abstra...

Neuronal PPP2R5C in plasma is a potential biomarker for early diagnosis of Alzheimer’s disease 【Highlights】 •PPP2R5C is an early-declining marker across pre-sym...

Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization 【ABSTRACT】...

Plasma p-tau species are elevated in presymptomatic and symptomatic neuronal intranuclear inclusion disease 【Background】 Neuronal intranuclear inclusion disease (NIID), c...